Physiol. Genomics Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (August 23, 2005). doi:10.1152/physiolgenomics.00134.2005
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Figures
Right arrow All Versions of this Article:
24/2/97    most recent
00134.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olaso, R.
Right arrow Articles by Melki, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olaso, R.
Right arrow Articles by Melki, J.
Submitted on June 8, 2005
Accepted on August 9, 2005

Activation of RNA metabolism related genes in mouse but not human tissues deficient in SMN

Robert Olaso1, Vandana Joshi1, Julien Fernandez1, Natacha Roblot1, Sabrina Courageot1, Jean Paul Bonnefont2, and Judith Melki1*

1 E223, INSERM, Evry, Ile de France, France
2 U393, INSERM, Paris, Ile de France, France

* To whom correspondence should be addressed. E-mail: j.melki{at}genopole.inserm.fr.

Mutations of the survival of motor neuron gene (SMN1) are responsible for spinal muscular atrophies (SMA), a frequent recessive autosomal motor neuron disease. SMN is involved in various processes including RNA metabolism. However, the molecular pathway linking marked deficiency of SMN to SMA phenotype remains unclear. Homozygous deletion of murine Smn exon 7 directed to neurons or skeletal muscle causes severe motor axonal or myofiber degeneration, respectively. Using cDNA microarrays, expression profiles of 8400 genes were analyzed in skeletal muscle and spinal cord of muscular and neuronal mutants, respectively and compared to age-matched controls. A high proportion of genes (20 out of 429, 5%) was involved in pre-mRNA splicing, ribosomal RNA processing or RNA decay and 18 of them were upregulated in mutant tissues. By analysing other neuromuscular disorders, we showed that most of them (14 out of 18) were specific to the SMN defect. Quantitative PCR analysis of these transcripts showed that gene activation was an early adaptive response to the lack but not reduced amount of full length SMN in mouse mutant tissues. In human SMA tissues, activation of this program was not observed which could be ascribed to the reduction but not the absence of full length SMN.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. Vitte, C. Fassier, F. D. Tiziano, C. Dalard, S. Soave, N. Roblot, C. Brahe, P. Saugier-Veber, J. P. Bonnefont, and J. Melki
Refined Characterization of the Expression and Stability of the SMN Gene Products
Am. J. Pathol., October 1, 2007; 171(4): 1269 - 1280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.